SPOP and MMR/MSI alterations in prostate cancer: relationship with PD-L1, TILs and AR expression
{{output}}
Objective: Despite the promising introduction of anti-PD-L1 therapy for advanced stage of prostate cancer (PCa), recent studies have demonstrated limited success, suggesting the need to improve patient selection. ... ...
